Positron emission tomography in recurrent hepatoblastoma

Pediatric Surgery International

Volumn 21, Issue 5, 2005, Pages 341-345

  Philip, Isaac ^a   Shun, Albert ^a   McCowage, Geoffrey ^a   Howman Giles, Robert ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Hepatoblastoma; Positron emission tomography

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADRENAL METASTASIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; INFANT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 18744361864     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-005-1406-9     Document Type: Article

References (24)

1. Spieth ME, Kasner DL (2002) A tabulated summary of FDG literature. J Nucl Med 43:441
2. Bar-Shalom R, Valdivia A, Blaufox MD (2000) PET imaging in oncology. Semin Nucl Med 30:150-185
3. Hustinx R, Benard F, Alavi A (2002) Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med 32:35-46
4. Shulkin BL, Mitchell DS, Ungar DR, et al. (1995) Neoplasms in a pediatric population: 2-(F-18) fluoro-2-deoxy-D-glucose PET studies. Radiology 194:495-500
5. Hoffman JM, Hanson MW, Friedman HS, et al. (1992) FDG-PET in pediatric posterior fossa brain tumors. J Comput Assist Tomogr 16:62-68
6. O'Hara SM, Donnelly LF, Coleman RE (1999) Pediatric body applications of FDG PET. AJR Am J Roentgenol 172:1019-1024
7. Shulkin BL, Hutchinson RJ, Castle VP, Yank GA, Shapiro B, Sisson JC (1996) Neuroblastoma: positron emission tomography with 2-(fluorine-18)-fluoro- 2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 199:743-750
8. Hahn K, Pfluger T (2004) Has PET become an important tool in paediatric imaging? Eur J Nucl Med Mol Imaging 4:1470-1478
9. Sironi S, Messa C, Cistaro A, Landoni C, Provenzi M, Giraldi E, Sonzogni A, Fazio F (2004) Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG positron emission tomography. Am J Roentgenol 182:1214-1216
10. Trojan J, Schroeder O, Raedle J, et al. (1999) Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94:3314-3319
11. Khan MA, Combs CS, Brunt EM, et al. (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792-797
12. Delbeke D, Martin W, Sandler MP, et al. (1998) Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg 133:510-516
13. Ho CL, Yu SCH, Yeung DWC (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 44:213-221
14. King DR (1998) Liver tumours. In: O'Neill Jr JA, Rowe MI, Grosfeld JL, Fonkalsrud EW, Coran AG (eds) Pediatric surgery. Mosby Year Book, St. Louis, pp 21-430
15. Charron M, Beyer T, Bohnen NN, et al. (2000) Image analysis in patients with cancer studied with combined PET and CT scanner. Clin Nucl Med 25:905-910
16. Hutton BF, Braun M, Thurfjell L, Lau DY (2002) Image registration: an essential tool for nuclear medicine. Eur J Nucl Med Mol Imaging 29:559-577
17. Nagasue N (1983) Gallium scanning in the diagnosis of hepatocellular carcinoma: a clinicopathological study of 45 patients. Clin Radiol 34:139
18. Howman-Giles R, Bernard EJ, Uren R (1997) Pediatric nuclear oncology. Q J Nucl Med 41:321-335
19. Bernard EJ, Nicholls W, Howman-Giles R, Kan A, Stevens M (1997) T1201 positive, Ga-67 negative hepatoblastoma: a case report of a 12 years old boy. Clin Nucl Med 22:835-837
20. Kairemo KJ, Lindahl H, Merenmies J, et al. (2002) Anti-alphafetoprotein imaging is useful for staging hepatoblastoma. Transplantation 73:1151-1154
21. Wagner HN Jr (1998) A brief history of positron emission tomography (PET). Semin Nucl Med 28:213-220
22. Warburg O (1931) Metabolism of tumors. Smith RR, New York
23. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
24. Kostakoglu L, Agress H, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23:315-340